$CLOV stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $18,757,434 of trading volume.
Here is what we see in our data on $CLOV (you can track the company live on Quiver's $CLOV stock page):
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- ANDREW TOY (Chief Executive Officer) has made 0 purchases and 5 sales selling 844,967 shares for an estimated $3,995,594.
- CONRAD WAI (CEO, Counterpart Health) has made 0 purchases and 4 sales selling 568,268 shares for an estimated $2,519,158.
- KAREN SOARES (Chief Legal Officer) has made 0 purchases and 6 sales selling 107,694 shares for an estimated $495,085.
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 13 sales selling 86,859 shares for an estimated $407,947.
- JOSEPH CLAY THORNTON (Chief Financial Officer) has made 0 purchases and 4 sales selling 49,095 shares for an estimated $230,972.
- JOSEPH FRANK OLDAKOWSKI (VP OF FINANCE AND CONTROLLER) has made 0 purchases and 3 sales selling 35,272 shares for an estimated $176,724.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CLOV Hedge Fund Activity
We have seen 122 institutional investors add shares of $CLOV stock to their portfolio, and 108 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 5,521,188 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $23,796,320
- VANGUARD PORTFOLIO MANAGEMENT LLC added 3,120,475 shares (+69.8%) to their portfolio in Q3 2026, for an estimated $13,449,247
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 1,959,444 shares (-80.9%) from their portfolio in Q3 2026, for an estimated $8,445,203
- RENAISSANCE TECHNOLOGIES LLC added 1,746,800 shares (+62.2%) to their portfolio in Q3 2026, for an estimated $7,528,707
- D. E. SHAW & CO., INC. added 1,682,803 shares (+595.3%) to their portfolio in Q2 2026, for an estimated $8,817,887
- HRT FINANCIAL LP removed 1,667,691 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $8,738,700
- MARSHALL WACE, LLP removed 1,563,189 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $6,737,344
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 10/28/2026
- Canaccord Genuity issued a "Buy" rating on 07/21/2026
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
$CLOV Price Targets
Multiple analysts have issued price targets for $CLOV recently. We have seen 3 analysts offer price targets for $CLOV in the last 6 months, with a median target of $5.5.
Here are some recent targets:
- Jonathan Yong from UBS set a target price of $5.5 on 11/05/2026
- Matthew Shea from Needham set a target price of $6.0 on 10/28/2026
- Richard Close from Canaccord Genuity set a target price of $5.5 on 07/21/2026
You can track data on $CLOV on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.